These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25715137)

  • 1. [Internationalization, science and health: global regenerative medicine and the parallel markets].
    Acero L
    Cien Saude Colet; 2015 Feb; 20(2):433-40. PubMed ID: 25715137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health consumers and stem cell therapy innovation: markets, models and regulation.
    Salter B; Zhou Y; Datta S
    Regen Med; 2014 May; 9(3):353-66. PubMed ID: 24935045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.
    Fernández-Avilés F; Sanz-Ruiz R; Climent AM; Badimon L; Bolli R; Charron D; Fuster V; Janssens S; Kastrup J; Kim HS; Lüscher TF; Martin JF; Menasché P; Pinto FJ; Simari RD; Stone GW; Terzic A; Willerson JT; Wu JC;
    Circ Res; 2018 Jan; 122(2):199-201. PubMed ID: 29348246
    [No Abstract]   [Full Text] [Related]  

  • 4. Olympic and world sport: making transnational society?
    Giulianotti R; Brownell S
    Br J Sociol; 2012 Jun; 63(2):199-215. PubMed ID: 22670644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From coastal to global: The transnational flow of Ayurveda and its relevance for Indo-African linkages.
    Meier Zu Biesen C
    Glob Public Health; 2018 Mar; 13(3):339-354. PubMed ID: 28125930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The globalization of football: a study in the glocalization of the 'serious life'.
    Giulianotti R; Robertson R
    Br J Sociol; 2004 Dec; 55(4):545-68. PubMed ID: 15663424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The social management of biomedical novelty: Facilitating translation in regenerative medicine.
    Gardner J; Webster A
    Soc Sci Med; 2016 May; 156():90-7. PubMed ID: 27019143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells and regenerative medicine on the Asian horizon: an economic, industry and social perspective.
    Sipp D
    Regen Med; 2009 Nov; 4(6):911-8. PubMed ID: 19903008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International standards and guidelines on education and training for the multi-disciplinary health response to major events that threaten the health status of a community.
    Seynaeve G; Archer F; Fisher J; Lueger-Schuster B; Rowlands A; Sellwood P; Vandevelde K; Zigoura A;
    Prehosp Disaster Med; 2004; 19(2):S17-30. PubMed ID: 15506258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding health systems, health economies and globalization: the need for social science perspectives.
    Murray SF; Bisht R; Baru R; Pitchforth E
    Global Health; 2012 Aug; 8():30. PubMed ID: 22938504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory brokerage: Competitive advantage and regulation in the field of regenerative medicine.
    Sleeboom-Faulkner M
    Soc Stud Sci; 2019 Jun; 49(3):355-380. PubMed ID: 31185876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global generations: social change in the twentieth century.
    Edmunds J; Turner BS
    Br J Sociol; 2005 Dec; 56(4):559-77. PubMed ID: 16309436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Academic review of global health approaches: an analytical framework].
    Franco-Giraldo A
    Cad Saude Publica; 2015 Sep; 31(9):1811-23. PubMed ID: 26578006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framing global health: the governance challenge.
    McInnes C; Kamradt-Scott A; Lee K; Reubi D; Roemer-Mahler A; Rushton S; Williams OD; Woodling M
    Glob Public Health; 2012; 7 Suppl 2():S83-94. PubMed ID: 23113870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying viable regulatory and innovation pathways for regenerative medicine: a case study of cultured red blood cells.
    Mittra J; Tait J; Mastroeni M; Turner ML; Mountford JC; Bruce K
    N Biotechnol; 2015 Jan; 32(1):180-90. PubMed ID: 25094050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-health internationalization requirements for audit purposes.
    Ouhbi S; Fernández-Alemán JL; Carrillo-de-Gea JM; Toval A; Idri A
    Comput Methods Programs Biomed; 2017 Jun; 144():49-60. PubMed ID: 28495006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization as situation-specific achievement: regulatory diversity and the production of value in intercontinental collaborations in stem cell medicine.
    Rosemann A
    Soc Sci Med; 2014 Dec; 122():72-80. PubMed ID: 25441319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ES Cell International & regenerative medicine.
    Colman A; Alliston D
    Regen Med; 2006 Mar; 1(2):287-91. PubMed ID: 17465812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transnational healthcare practices of Romanian migrants in Ireland: inequalities of access and the privatisation of healthcare services in Europe.
    Stan S
    Soc Sci Med; 2015 Jan; 124():346-55. PubMed ID: 24797693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.